Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Van Herk Group is a prominent Dutch private investment firm with a significant focus on the life sciences, biotechnology, and real estate sectors. Founded by entrepreneur Aat van Herk, the group is recognized as one of the most influential private investors in the European biotech landscape. It typically takes long-term, strategic positions in companies, supporting them through various stages of clinical development and commercialization using an "evergreen" capital model. Notable past and present portfolio companies include Galapagos, Pharming Group, BioConnection, and SkylineDx. The firm provides not only capital but also strategic guidance through its extensive network and expertise in the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Van Herk Group.